Low-dose aspirin for the prevention of atherothrombosis

N Engl J Med. 2005 Dec 1;353(22):2373-83. doi: 10.1056/NEJMra052717.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Arteriosclerosis / prevention & control*
  • Aspirin / administration & dosage*
  • Aspirin / adverse effects
  • Aspirin / pharmacokinetics
  • Cyclooxygenase 1 / metabolism
  • Cyclooxygenase Inhibitors / administration & dosage*
  • Cyclooxygenase Inhibitors / adverse effects
  • Cyclooxygenase Inhibitors / pharmacokinetics
  • Drug Interactions
  • Drug Resistance
  • Gastrointestinal Hemorrhage / chemically induced
  • Humans
  • Male
  • Myocardial Infarction / prevention & control
  • Platelet Aggregation Inhibitors / administration & dosage*
  • Platelet Aggregation Inhibitors / adverse effects
  • Platelet Aggregation Inhibitors / pharmacokinetics
  • Risk
  • Stroke / prevention & control
  • Thrombosis / prevention & control*
  • Thromboxane A2 / biosynthesis
  • Thromboxane A2 / physiology

Substances

  • Cyclooxygenase Inhibitors
  • Platelet Aggregation Inhibitors
  • Thromboxane A2
  • Cyclooxygenase 1
  • Aspirin